No Data
No Data
Weiss Healthcare (688580.SH): A total cost of 13.107 million yuan to buy back 0.3467% of the shares
Gelonghui, April 1 | Weisi Healthcare (688580.SH) announced that as of March 31, 2024, the company had repurchased a total of 237,893 shares of the company through centralized bidding transactions through the Shanghai Stock Exchange, accounting for 0.3467% of the company's total share capital. The highest price of the repurchase transaction was 65.88 yuan/share, the lowest price was 41.23 yuan/share, and the total amount of capital paid was RMB 13,107,011.20 (excluding transaction fees such as stamp duty and transaction fees).
Nanjing Vishee Medical Technology Co., Ltd (SHSE:688580) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
With its stock down 22% over the past three months, it is easy to disregard Nanjing Vishee Medical Technology (SHSE:688580). But if you pay close attention, you might find that its key financial ind
Express News | Cinda Securities: Focus on investment opportunities brought about by medical equipment updates
Weiss Healthcare (688580.SH): No implantable neuromodulation products are currently being developed or sold
Gelonghui, March 11 | Weiss Healthcare (688580.SH) said on the investor interactive platform, according to the World Neuromodulation Society's definition of “neuroregulation” — that is, in the field of combining technology, medical treatment, and bioengineering technology, signals are transmitted to neurons or neural networks in the central, peripheral, and neighboring or remote parts of the autonomic nervous system through electrical or chemical effects, thereby improving patients' quality of life or improving body function. The company currently has long-term business in the field of non-implantable neuromodulation
Weiss Healthcare (688580.SH): Accumulated repurchases of 237,900 shares
Gelonghui, March 1, 丨 Weisi Healthcare (688580.SH) announced that as of February 29, 2024, the company had repurchased a total of 237,893 shares of the company through centralized bidding transactions through the Shanghai Stock Exchange, accounting for 0.3467% of the company's total share capital. The highest price of the repurchase transaction was 65.88 yuan/share, the lowest price was 41.23 yuan/share, and the total amount of capital paid was RMB 13,107,011.20 (excluding transaction fees such as stamp duty and transaction fees).
Weiss Healthcare (688580) 2023 Earnings Report Review: Steady Growth in Q4 Performance, Innovation Drives Business Structure Optimization
Incident: The company released its 2023 performance report. It achieved operating income, net profit to mother, and net profit after deducting non-return to mother for the whole year of 4.62/1.36/ 122 million yuan, respectively, +43.72%/45.41% /58 compared to the same period last year
No Data